pmcc logo sml


 Here are the staff publications for October 2023.

Compiled by the Health Sciences Library (RMH, RWH, PMCC & Victorian Mental Health) 1st November 2023.


  1. Ali I, Silva J, Casillas-Espinosa PM, Braine E, Yamakawa GR, Hudson MR, Brady RD, Major B, Thergarajan P, Haskali MB, Wright DK, Jupp B, Vivash L, Shultz SR, Mychasiuk R, Kwan P, Jones NC, Fukushima K, Sachdev P, Cheng JY, O'Brien TJ. E2730, an uncompetitive gamma-aminobutyric acid transporter-1 inhibitor, suppresses epileptic seizures in a rat model of chronic mesial temporal lobe epilepsy. Epilepsia 2023;64:2806-17.
  2. Allen CG, Olstad DL, Kahkoska AR, Guan Y, Ramos PS, Steinberg J, Staras SAS, Lumpkins CY, Milko LV, Turbitt E, Rahm AK, Saylor KW, Best S, Hatch A, Santangelo I, Roberts MC. Extending an Antiracism Lens to the Implementation of Precision Public Health Interventions. Am J Public Health 2023;113:1210-8.
  3. Bearz A, Martini JF, Jassem J, Kim SW, Chang GC, Shaw AT, Shepard DA, Dall'O E, Polli A, Thurm H, Zalcman G, Garcia Campelo MR, Penkov K, Hayashi H, Solomon BJ. Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations. J Thorac Oncol 2023;18:1581-93.
  4. Blom M, Zhang H, Tescher A, Dixon B, Magarey M. Staged neck dissection prior to transoral robotic surgery for oropharyngeal cancer: does it reduce post-operative complication rates? A multi-centre study of 104 patients. Eur Arch Otorhinolaryngol 2023;280:5067-72.
  5. Brown KGM, Solomon MJ, Heriot A, Frizelle F. Treatment of locally advanced and recurrent rectal cancer in Australia and New Zealand: recent progress and future challenges. ANZ J Surg 2023;93:2291-2.
  6. Bucknell NW, Hardcastle N, Woon B, Selbie L, Bressel M, Byrne K, Callahan J, Hanna GG, Hofman MS, Ball D, Kron T, Siva S. The HI-FIVE Trial: A Prospective Trial Using 4-Dimensional (68)Ga Ventilation-Perfusion Positron Emission Tomography-Computed Tomography for Functional Lung Avoidance in Locally Advanced Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2023;117:887-92.
  7. Chen K, Ong S, Vasundhara K, Mun CK, Williams I, Kanesvaran R, Peng JYS, Azad AA, Lawrentschuk N. Is genetic testing coming of age in advanced prostate cancer? BJU Int 2023;132:496-8.
  8. Chiu JWY, Lee SC, Ho JC, Park YH, Chao TC, Kim SB, Lim E, Lin CH, Loi S, Low SY, Teo LLS, Yeo W, Dent R. Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel. Drug Saf 2023;46:927-49.
  9. Chong K, Maida J, Ong HI, Proud D, Lin J, Burgess A, Heriot A, Smart P, Mohan H. Cancer incidence and outcomes registries in an Australian context: a systematic review. ANZ J Surg 2023;93:2314-36.
  10. Collins A, Hui D, Davison SN, Ducharlet K, Murtagh F, Chang YK, Philip J. Referral Criteria to Specialist Palliative Care for People with Advanced Chronic Kidney Disease: A Systematic Review. J Pain Symptom Manage 2023;66:541-50 e1.
  11. Cummins K, Gill S. Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia. Hematol Oncol Clin North Am 2023;37:1125-47.
  12. Diab A, Gogas H, Sandhu S, Long GV, Ascierto PA, Larkin J, Sznol M, Franke F, Ciuleanu TE, Pereira C, Munoz Couselo E, Bronzon Damian F, Schenker M, Perfetti A, Lebbe C, Quereux G, Meier F, Curti BD, Rojas C, Arriaga Y, Yang H, Zhou M, Ravimohan S, Statkevich P, Tagliaferri MA, Khushalani NI. Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. J Clin Oncol 2023;41:4756-67.
  13. Dummer R, Gyorki DE, Hyngstrom JR, Ning M, Lawrence T, Ross MI. Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical Trial. JAMA Oncol 2023;9:1457-9.
  14. Gilan O, Talarmain L, Bell CC, Neville D, Knezevic K, Ferguson DT, Boudes M, Chan YC, Davidovich C, Lam EYN, Dawson MA. CRISPR-ChIP reveals selective regulation of H3K79me2 by Menin in MLL leukemia. Nat Struct Mol Biol 2023;30:1592-606.
  15. Glyn T, Oar A, Vatandoust S, Heriot A, Jain A. Rectal cancer treatment: an embarrassment of riches? ANZ J Surg 2023;93:2293-4.
  16. Hoe HJ, Solomon BJ. Optimizing Dosing of Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always Better. J Clin Oncol 2023;41:4849-51.
  17. Howitt G, Feng Y, Tobar L, Vassiliadis D, Hickey P, Dawson MA, Ranganathan S, Shanthikumar S, Neeland M, Maksimovic J, Oshlack A. Benchmarking single-cell hashtag oligo demultiplexing methods. NAR Genom Bioinform 2023;5:lqad086.
  18. Humm GL, Peckham-Cooper A, Chang J, Fernandes R, Gomez NF, Mohan H, Nally D, Thaventhiran AJ, Zakeri R, Gupte A, Crosbie J, Wood C, Dawas K, Stoyanov D, Lovat LB. Surgical experience and identification of errors in laparoscopic cholecystectomy. Br J Surg 2023;110:1535-42.
  19. Inam F, Bergin RJ, Mizrahi D, Dunstan DW, Moore M, Maxwell-Davis N, Denehy L, Lynch BM, Swain CTV. Diverse strategies are needed to support physical activity engagement in women who have had breast cancer. Support Care Cancer 2023;31:648.
  20. Juneja M, Szer J. Commentary on the 2023 ASH guidelines for thrombophilia testing in venous thromboembolism. Blood Adv 2023;7:6428-9.
  21. Kazzi C, Kuznetsova V, Siriratnam P, Griffith S, Wong S, Tam CS, Alpitsis R, Spencer A, O'Brien TJ, Malpas CB, Monif M. Cognition following chimeric antigen receptor T-cell therapy: A systematic review. J Autoimmun 2023;140:103126.
  22. Kinsella PM, Yong MK, Slavin MA, Hall VG. Parvovirus B19 in stem cell transplantation. Transpl Infect Dis 2023;25:e14138.
  23. Kunz S, Ashraf H, Klonis C, Thompson SK, Aly A, Liu DS. Surgical approaches for achalasia and obesity: a systematic review and patient-level meta-analysis. Langenbecks Arch Surg 2023;408:403.
  24. Lawless A, Zhou DD, McDonough J, Lo H, Mar J, Lazarakis S, Ward I, Connor J, Thompson SR, Coker D, Johnston A, Gyorki DE, Hong AM. The role of radiation therapy in the management of primary retroperitoneal sarcoma: A systematic review and clinical practice guidelines from the Australia and New Zealand Sarcoma Association. Cancer Treat Rev 2023;120:102620.
  25. MacManus M, Kirby L, Blyth B, Banks O, Martin OA, Yeung MM, Plumridge N, Shaw M, Hegi-Johnson F, Siva S, Ball D, Wong SQ. Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC. Clin Transl Radiat Oncol 2023;43:100682.
  26. Mallardo D, Woodford R, Menzies AM, Zimmer L, Williamson A, Ramelyte E, Dimitriou F, Wicky A, Wallace R, Mallardo M, Cortellini A, Budillon A, Atkinson V, Sandhu S, Olivier M, Dummer R, Lorigan P, Schadendorf D, Long GV, Simeone E, Ascierto PA. The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab. J Transl Med 2023;21:753.
  27. Martis WR. The potential use of perioperative rectus femoris ultrasonography in guiding prehabilitation strategies. J Clin Anesth 2023;92:111302.
  28. McWilliam A, Palma G, Abravan A, Acosta O, Appelt A, Aznar M, Monti S, Onjukka E, Panettieri V, Placidi L, Rancati T, Vasquez Osorio E, Witte M, Cella L. Voxel-based analysis: Roadmap for clinical translation. Radiother Oncol 2023;188:109868.
  29. Mui M, Clark M, Vu T, Clemons N, Hollande F, Roth S, Ramsay R, Michael M, Heriot AG, Kong JCH. Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review. Langenbecks Arch Surg 2023;408:392.
  30. Naseem Z, Kaneko Y, Pham T. Colo-rectal fistula: a rare complication of diverticular disease. ANZ J Surg 2023;93:2517-8.
  31. Ng JY, Warwick L, Craft P, Austen L, Ashford B, Gorddard N, Ballinger ML, Thomas DM, Blombery P, Tucker K, Polizzotto MN. Myelodysplastic syndrome and multiple solid tumours in an individual with compound heterozygous deleterious FANCM variants: A case report and review of the literature. Br J Haematol 2023;203:481-4.
  32. Ng Liet Hing M, Khot A. Lenalidomide maintenance in Myeloma - a goldilocks problem? Leuk Lymphoma 2023;64:1611-4.
  33. Othman B, Pham T, Mohan H, Rajkomar A, Heriot AG, Smart P, Warrier S. Use of ureteric catheters and indocyanine green in complex pelvic surgery: a must or a luxury in 2023? ANZ J Surg 2023;93:2287-8.
  34. Parry EM, Lemvigh CK, Deng S, Dangle N, Ruthen N, Knisbacher BA, Broseus J, Hergalant S, Guieze R, Li S, Zhang W, Johnson C, Long JM, Yin S, Werner L, Anandappa A, Purroy N, Gohil S, Oliveira G, Bachireddy P, Shukla SA, Huang T, Khoury JD, Thakral B, Dickinson M, Tam C, Livak KJ, Getz G, Neuberg D, Feugier P, Kharchenko P, Wierda W, Olsen LR, Jain N, Wu CJ. ZNF683 marks a CD8(+) T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome. Cancer Cell 2023;41:1803-16 e8.
  35. Peel TN, Astbury S, Cheng AC, Paterson DL, Buising KL, Spelman T, Tran-Duy A, Adie S, Boyce G, McDougall C, Molnar R, Mulford J, Rehfisch P, Solomon M, Crawford R, Harris-Brown T, Roney J, Wisniewski J, de Steiger R. Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty. N Engl J Med 2023;389:1488-98.
  36. Raichurkar P, Denehy L, Solomon M, Koh C, Pillinger N, Hogan S, McBride K, Carey S, Bartyn J, Hirst N, Steffens D. Research Priorities in Prehabilitation for Patients Undergoing Cancer Surgery: An International Delphi Study. Ann Surg Oncol 2023;30:7226-35.
  37. Raichurkar P, Denehy L, Solomon M, Koh C, Pillinger N, Hogan S, McBride K, Carey S, Bartyn J, Hirst N, Steffens D, Prehabilitation Expert C. Research Priorities in Prehabilitation for Patients Undergoing Cancer Surgery: An International Delphi Study. Ann Surg Oncol 2023;30:7226-35.
  38. Raichurkar P, Denehy L, Solomon M, Koh C, Pillinger N, Hogan S, McBride K, Carey S, Bartyn J, Hirst N, Steffens D, Prehabilitation Expert C. ASO Visual Abstract: Research Priorities in Prehabilitation for Patients Undergoing Cancer Surgery-An International Delphi Study. Ann Surg Oncol 2023;30:7261-2.
  39. Ramsay RG, Whitehall V, Flood MP. Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer. Growth Factors 2023;41:179-91.
  40. Reynolds G, Cliff ERS, Mohyuddin GR, Popat R, Midha S, Liet Hing MN, Harrison SJ, Kesselheim AS, Teh BW. Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis. Blood Adv 2023;7:5898-903.
  41. Roberts ME, Rahman NM, Maskell NA, Bibby AC, Blyth KG, Corcoran JP, Edey A, Evison M, de Fonseka D, Hallifax R, Harden S, Lawrie I, Lim E, McCracken D, Mercer R, Mishra EK, Nicholson AG, Noorzad F, Opstad KS, Parsonage M, Stanton AE, Walker S. British Thoracic Society Guideline for pleural disease. Thorax 2023;78:1143-56.
  42. Rourke S, Dimech A, Bacon R, Paterson C. The lived experiences of critical care nurses during the COVID-19 pandemic. A qualitative systematic review. Intensive Crit Care Nurs 2023;80:103555.
  43. Russ BE, Barugahare A, Dakle P, Tsyganov K, Quon S, Yu B, Li J, Lee JKC, Olshansky M, He Z, Harrison PF, See M, Nussing S, Morey AE, Udupa VA, Bennett TJ, Kallies A, Murre C, Collas P, Powell D, Goldrath AW, Turner SJ. Active maintenance of CD8(+) T cell naivety through regulation of global genome architecture. Cell Rep 2023;42:113301.
  44. Seth R, Agarwala SS, Messersmith H, Alluri KC, Ascierto PA, Atkins MB, Bollin K, Chacon M, Davis N, Faries MB, Funchain P, Gold JS, Guild S, Gyorki DE, Kaur V, Khushalani NI, Kirkwood JM, McQuade JL, Meyers MO, Provenzano A, Robert C, Santinami M, Sehdev A, Sondak VK, Spurrier G, Swami U, Truong TG, Tsai KK, van Akkooi A, Weber J. Systemic Therapy for Melanoma: ASCO Guideline Update. J Clin Oncol 2023;41:4794-820.
  45. Sharma S, Chung CY, Uryu S, Petrovic J, Cao J, Rickard A, Nady N, Greasley S, Johnson E, Brodsky O, Khan S, Wang H, Wang Z, Zhang Y, Tsaparikos K, Chen L, Mazurek A, Lapek J, Kung PP, Sutton S, Richardson PF, Greenwald EC, Yamazaki S, Jones R, Maegley KA, Bingham P, Lam H, Stupple AE, Kamal A, Chueh A, Cuzzupe A, Morrow BJ, Ren B, Carrasco-Pozo C, Tan CW, Bhuva DD, Allan E, Surgenor E, Vaillant F, Pehlivanoglu H, Falk H, Whittle JR, Newman J, Cursons J, Doherty JP, White KL, MacPherson L, Devlin M, Dennis ML, Hattarki MK, De Silva M, Camerino MA, Butler MS, Dolezal O, Pilling P, Foitzik R, Stupple PA, Lagiakos HR, Walker SR, Hediyeh-Zadeh S, Nuttall S, Spall SK, Charman SA, Connor T, Peat TS, Avery VM, Bozikis YE, Yang Y, Zhang M, Monahan BJ, Voss AK, Thomas T, Street IP, Dawson SJ, Dawson MA, Lindeman GJ, Davis MJ, Visvader JE, Paul TA. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer. Cell Chem Biol 2023;30:1191-210 e20.
  46. Smith IS, Bind MA, Weihs KL, Bei B, Wiley JF. Targeting emotional regulation using an Internet-delivered psychological intervention for cancer survivors: A randomized controlled trial. Br J Health Psychol 2023;28:1185-205.
  47. Soo RA, Martini JF, van der Wekken AJ, Teraoka S, Ferrara R, Shaw AT, Shepard D, Calella AM, Polli A, Toffalorio F, Tomasini P, Chiu CH, Kowalski DM, Kim HR, Solomon BJ. Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC. J Thorac Oncol 2023;18:1568-80.
  48. Steffens D, Denehy L, Solomon M, Koh C, Ansari N, McBride K, Carey S, Bartyn J, Lawrence AS, Sheehan K, Delbaere K. Consumer Perspectives on the Adoption of a Prehabilitation Multimodal Online Program for Patients Undergoing Cancer Surgery. Cancers (Basel) 2023;15.
  49. Terriou L, Lee JW, Forsyth C, Griffin M, Szer J, Röth A, Gustovic P, Metzger J, Patel AS, Patriquin CJ. Long-term effectiveness of eculizumab: Data from the International PNH Registry. Eur J Haematol 2023;111:796-804.
  50. Thai AA, Young RJ, Bressel M, Angel C, McDowell L, Tiong A, Bucknell NW, Fellowes A, Xu H, Trigos A, Rischin D, Solomon BJ. Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma. Br J Dermatol 2023;189:588-602.
  51. Tio SY, Chen SC, Hamilton K, Heath CH, Pradhan A, Morris AJ, Korman TM, Morrissey O, Halliday CL, Kidd S, Spelman T, Brell N, McMullan B, Clark JE, Mitsakos K, Hardiman RP, Williams P, Campbell AJ, Beardsley J, Van Hal S, Yong MK, Worth LJ, Slavin MA. Invasive aspergillosis in adult patients in Australia and New Zealand: 2017-2020. Lancet Reg Health West Pac 2023;40:100888.
  52. van der Pol Y, Moldovan N, Ramaker J, Bootsma S, Lenos KJ, Vermeulen L, Sandhu S, Bahce I, Pegtel DM, Wong SQ, Dawson SJ, Chandrananda D, Mouliere F. The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection. Genome Biol 2023;24:229.
  53. Vargas C, Haeusler GM, Slavin MA, Babl FE, Mechinaud F, Phillips R, Thursky K, Lourenco RA. An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia. Pediatr Blood Cancer 2023;70:e30633.
  54. Vijan A, Khoshpouri P, Murphy AN, Gala F. Glutaric Aciduria Type 1. Radiographics 2023;43:e230114.
  55. Wollner EA, Nourian MM, Bertille KK, Wake PB, Lipnick MS, Whitaker DK. Capnography-An Essential Monitor, Everywhere: A Narrative Review. Anesth Analg 2023;137:934-42.
  56. Wrenn RH, Trubiano JA. Penicillin Allergy Impact and Management. Infect Dis Clin North Am 2023;37:793-822.
  57. Xu J, Mohan HM, Fleming C, Larach JT, Apte SS, Cohen LCL, Miskovic D, Jiang W, Heriot AG, Warrier SK. Complete mesocolic excision versus standard resection for colon cancer: a systematic review and meta-analysis of perioperative safety and an evaluation of the use of a robotic approach. Tech Coloproctol 2023;27:995-1005.
  58. Xu M, Lasocki A, Bressel M, Goroncy N, Wheeler G, Dwyer M, Wiltshire K, Seymour JF, Haghighi N, Mason K, Tange D, Campbell BA. Favourable outcomes with an initial active surveillance strategy for asymptomatic radiation-induced meningiomas in long-term survivors of paediatric and young adult malignancies. Radiother Oncol 2023;189:109916.
  59. Yeoh DK, McMullan BJ, Clark JE, Slavin MA, Haeusler GM, Blyth CC. The Challenge of Diagnosing Invasive Pulmonary Aspergillosis in Children: A Review of Existing and Emerging Tools. Mycopathologia 2023;188:731-43.
  60. Zaorsky NG, Louie AV, Siva S. Radiation therapy options in kidney cancer. Curr Opin Support Palliat Care 2023;17:308-14.
  61. Zaorsky NG, Louie AV, Siva S. Radiation Therapy for Renal Cell Carcinoma. Int J Radiat Oncol Biol Phys 2023;117:523-5.

Contact Details and Hours

(03) 9138 0580
(03) 9342 8615
M - F: 8:30am - 5pm

Library Manager

Susan Monaghan

Health Sciences Library

Royal Melbourne Hospital – City Campus

Ground floor - North

Grattan Street


Learning Resource Centre

Level 7A, Peter MacCallum Cancer Centre

305 Grattan Street